132 results on '"BRILOT, FABIENNE"'
Search Results
2. Oral corticosteroid dosage and tapeduration at onset in myelin oligodendrocyte glycoprotein antibody-associated disease influences time to first relapse
3. Success without intervention: keeping the conversation open
4. The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-associated disease
5. Cross-Sectional and Longitudinal Genotype to Phenotype Surveillance of SARS-CoV-2 Variants Over the First Four Years of the COVID-19 Pandemic
6. International MOGAD criteria
7. A longitudinal analysis of brain volume changes in myelin oligodendrocyte glycoprotein antibody‐associated disease
8. TMPRSS2 activation of Omicron lineage Spike glycoproteins is regulated by TMPRSS2 cleavage of ACE2
9. 8 Dosing of oral corticosteroid therapy and the risk of relapse at the onset of MOGAD
10. 6 Spike antibody seroconversion and emerging variant cross-reactivity following COVID-19 third vaccination dose in Australian people with multiple Sclerosis
11. Infection and Vaccine Induced Spike Antibody Responses Against SARS-CoV-2 Variants of Concern in COVID-19-Naïve Children and Adults
12. Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level
13. Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF
14. Origins and immunopathogenesis of autoimmune central nervous system disorders
15. Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19
16. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria
17. Humoral signatures of MOG-antibody-associated disease track with age and disease activity
18. Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sublineages in the face of maturing antibody breadth at the population level
19. Infection and vaccine induced Spike antibody responses against SARS-CoV-2 Variants of concern in immune naïve children and adults
20. Targeting B cell dysregulation with emerging therapies in autoimmune demyelinating disorders
21. 2432 Spike antibody seroconversion and breadth following SARS-CoV-2 vaccination in Australian people with Multiple Sclerosis
22. Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti‐spike neutralizing IgG to SARS‐CoV ‐2 variants, but preserved antigen‐specific T cell responses
23. Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia
24. Clonal dynamics of SARS-CoV-2-specific T cells in children and adults with COVID-19
25. SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
26. Emergence and Antibody Evasion of BQ and BA.2.75 SARS-CoV-2 Sublineages in the Face of Maturing Antibody Breadth at the Population Level
27. Emerging evidence of Toll-like receptors as a putative pathway linking maternal inflammation and neurodevelopmental disorders in human offspring: A systematic review
28. SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
29. Reply to “Investigating the immunopathogenic mechanisms underlying MOGAD ”
30. Efficacy of Vaccine BNT162b2 (Pfizer-BioNTech) in Individuals with Waldenstrom's Macroglobulinemia and Follicular Lymphoma in Australia
31. Validation of a Flow Cytometry Live Cell-Based Assay to Detect Myelin Oligodendrocyte Glycoprotein Antibodies for Clinical Diagnostics
32. Complement Activation Is a Prominent Feature ofMOGAD
33. Structural and functional markers of optic nerve damage in myelin oligodendrocyte glycoprotein antibody-associated optic neuritis
34. Cerebrospinal fluid free light chain quantitation is a specific biomarker for inflammatory neurological disorders in a paediatric patient cohort
35. MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis
36. Myelin-oligodendrocyte glycoprotein antibody-associated disease
37. Leucine‐Rich Glioma‐Inactivated 1 versus Contactin‐Associated Protein‐like 2 Antibody Neuropathic Pain: Clinical and Biological Comparisons
38. 007 Immunotherapy responsive neuropathic pain associated with LGI1 and CASPR2 antibodies
39. SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants
40. Maternal autoimmunity and inflammation are associated with childhood tics and obsessive-compulsive disorder: Transcriptomic data show common enriched innate immune pathways
41. MRI Patterns Distinguish Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis (4128)
42. Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection
43. Maternal acute and chronic inflammation in pregnancy is associated with common neurodevelopmental disorders: a systematic review
44. Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody‐associated disease
45. SARS-CoV-2 neutralizing antibodies; longevity, breadth, and evasion by emerging viral variants
46. Long-term persistence of neutralizing memory B cells in SARS-CoV-2
47. Single-cell approaches to investigate B cells and antibodies in autoimmune neurological disorders
48. Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation
49. International multicenter examination of MOG antibody assays
50. PRES-like presentation in MOG antibody-related demyelination (MARD)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.